SE301652B - - Google Patents

Info

Publication number
SE301652B
SE301652B SE1469364A SE1469364A SE301652B SE 301652 B SE301652 B SE 301652B SE 1469364 A SE1469364 A SE 1469364A SE 1469364 A SE1469364 A SE 1469364A SE 301652 B SE301652 B SE 301652B
Authority
SE
Sweden
Application number
SE1469364A
Inventor
A Gagneux
F Haefliger
C Eugster
Original Assignee
Geigy Ag J R
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geigy Ag J R filed Critical Geigy Ag J R
Publication of SE301652B publication Critical patent/SE301652B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/12Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE1469364A 1963-12-06 1964-12-04 SE301652B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1495463A CH427803A (de) 1963-12-06 1963-12-06 Verfahren zur Herstellung eines neuen Isoxazolderivates

Publications (1)

Publication Number Publication Date
SE301652B true SE301652B (de) 1968-06-17

Family

ID=4405150

Family Applications (3)

Application Number Title Priority Date Filing Date
SE1469364A SE301652B (de) 1963-12-06 1964-12-04
SE27767A SE304513B (de) 1963-12-06 1967-01-09
SE27667A SE303507B (de) 1963-12-06 1967-01-09

Family Applications After (2)

Application Number Title Priority Date Filing Date
SE27767A SE304513B (de) 1963-12-06 1967-01-09
SE27667A SE303507B (de) 1963-12-06 1967-01-09

Country Status (12)

Country Link
US (1) US3242190A (de)
AT (2) AT249054B (de)
BE (1) BE656759A (de)
CH (1) CH427803A (de)
DE (1) DE1445848A1 (de)
DK (4) DK106733C (de)
ES (5) ES306818A1 (de)
FR (2) FR1427775A (de)
GB (1) GB1034939A (de)
IL (1) IL22568A (de)
NL (1) NL6414138A (de)
SE (3) SE301652B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL130992C (de) * 1964-09-14
DK150615C (da) * 1982-10-26 1987-11-09 Cheminova As Fremgangsmaade til fremstilling af substituerede 3-isoxazololer
AU2002215160A1 (en) 2000-11-30 2002-06-11 Pfizer Products Inc. Combination of gaba agonists and aldose reductase inhibitors
AP2001002360A0 (en) 2000-11-30 2001-12-31 Pfizer Prod Inc Combination of gaba agonists and sorbitol dehydrogenase inhibitors.
JP2006528676A (ja) * 2003-05-16 2006-12-21 ファイザー・プロダクツ・インク 非定形型抗精神病薬と、gaba調節薬及び/又は抗痙攣薬の治療上の組合せ
EP1691811B1 (de) 2003-12-11 2014-07-23 Sunovion Pharmaceuticals Inc. Kombination aus einem sedativum und einem neurotransmitter-modulator und verfahren zur verbesserung der schlafqualität und zur behandlung von depression
JP2007537151A (ja) * 2004-01-29 2007-12-20 ファイザー・プロダクツ・インク γ−アミノ酪酸モジュレータと5−HT1B受容体アンタゴニストとの組合せ
EP2258359A3 (de) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenese durch Modulation des Muscarinrezeptors mit Sabcomelin
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス,インコーポレイティド ムスカリン性受容体調節による神経発生
CA2625153A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by pde inhibition
US20070112017A1 (en) * 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) * 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
WO2007104035A1 (en) * 2006-03-08 2007-09-13 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
EP2377531A2 (de) 2006-05-09 2011-10-19 Braincells, Inc. Neurogenese mittels Angiotensin-Modulation
US20100009983A1 (en) * 2006-05-09 2010-01-14 Braincells, Inc. 5 ht receptor mediated neurogenesis
WO2008030651A1 (en) * 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
CA2663347A1 (en) * 2006-09-19 2008-03-27 Braincells, Inc. Ppar mediated modulation of neurogenesis
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Also Published As

Publication number Publication date
FR1427775A (fr) 1966-02-11
AT249054B (de) 1966-09-26
BE656759A (de) 1965-06-08
GB1034939A (en) 1966-07-06
DK108169C (da) 1967-10-02
ES306819A1 (es) 1965-05-16
ES306816A1 (es) 1965-05-16
DE1445848A1 (de) 1968-11-21
ES306820A1 (es) 1965-05-16
AT250348B (de) 1966-11-10
DK106797C (da) 1967-03-20
FR4139M (de) 1966-05-02
US3242190A (en) 1966-03-22
CH427803A (de) 1967-01-15
DK106796C (da) 1967-03-20
SE304513B (de) 1968-09-30
DK106733C (da) 1967-03-13
IL22568A (en) 1968-04-25
NL6414138A (de) 1965-06-07
ES306818A1 (es) 1965-05-16
SE303507B (de) 1968-09-02
ES306817A1 (es) 1965-05-16

Similar Documents

Publication Publication Date Title
AR142945A1 (de)
FR4139M (de)
AT260747B (de)
BE627012A (de)
BE603935A (de)
BE625825A (de)
BE627023A (de)
BE635713A (de)
BE627172A (de)
BE627151A (de)
BE627145A (de)
BE626986A (de)
BE626938A (de)
BE626915A (de)
BE626867A (de)
BE626826A (de)
BE627141A (de)
BE626803A (de)
BE644524A (de)
BE626358A (de)
BE625880A (de)
BE625828A (de)
BE627083A (de)
BE625136A (de)
BE624982A (de)